Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Church

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Western Journal of Medicine|August 1, 1994
Syphilitic uveitisW W Emmons, L W Church
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2000
Media notification of the Michigan influenza outbreak, 1999-2000D H Havlichek, L W Church, D Sienko
The Annals of Otology, Rhinology, and Laryngology|August 1, 1995
Quantitative bacteriology of tonsils removed from children with tonsillitis hypertrophy and recurrent tonsillitis with and without hypertrophyJ J Kuhn, I Brook, C L Waters, et al.
The Journal of Infectious Diseases|June 2, 1998
Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxisD J Fryauff, S J Cryz, H Widjaja, et al.
Vaccine|March 17, 1999
Lymphocyte response to tetanus toxin T-cell epitopes: effects of tetanus vaccination and concurrent malaria prophylaxisD J Fryauff, E Mouzin, L W Church, et al.
The Journal of Infectious Diseases|December 12, 1997
Lymphocyte response to tetanus toxoid among Indonesian men immunized with tetanus-diphtheria during extended chloroquine or primaquine prophylaxisD J Fryauff, L W Church, A L Richards, et al.
Vaccine|June 2, 1998
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvantsT P Le, L W Church, G Corradin, et al.
The Journal of Infectious Diseases|April 1, 1997
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challengeL W Church, T P Le, J P Bryan, et al.
The Journal of Infectious Diseases|June 2, 1998
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malariaC F Ockenhouse, P F Sun, D E Lanar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Western Journal of Medicine|August 1, 1994
Syphilitic uveitisW W Emmons, L W Church
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2000
Media notification of the Michigan influenza outbreak, 1999-2000D H Havlichek, L W Church, D Sienko
The Annals of Otology, Rhinology, and Laryngology|August 1, 1995
Quantitative bacteriology of tonsils removed from children with tonsillitis hypertrophy and recurrent tonsillitis with and without hypertrophyJ J Kuhn, I Brook, C L Waters, et al.
The Journal of Infectious Diseases|June 2, 1998
Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxisD J Fryauff, S J Cryz, H Widjaja, et al.
Vaccine|March 17, 1999
Lymphocyte response to tetanus toxin T-cell epitopes: effects of tetanus vaccination and concurrent malaria prophylaxisD J Fryauff, E Mouzin, L W Church, et al.
The Journal of Infectious Diseases|December 12, 1997
Lymphocyte response to tetanus toxoid among Indonesian men immunized with tetanus-diphtheria during extended chloroquine or primaquine prophylaxisD J Fryauff, L W Church, A L Richards, et al.
Vaccine|June 2, 1998
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvantsT P Le, L W Church, G Corradin, et al.
The Journal of Infectious Diseases|April 1, 1997
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challengeL W Church, T P Le, J P Bryan, et al.
The Journal of Infectious Diseases|June 2, 1998
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malariaC F Ockenhouse, P F Sun, D E Lanar, et al.
Pageof 1